Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Work In Process (2016 - 2019)

Tandem Diabetes Care's Work In Process history spans 6 years, with the latest figure at $3.6 million for Q1 2019.

  • For Q1 2019, Work In Process fell 5.34% year-over-year to $3.6 million; the TTM value through Mar 2019 reached $3.6 million, down 5.34%, while the annual FY2018 figure was $2.7 million, 28.91% down from the prior year.
  • Work In Process reached $3.6 million in Q1 2019 per TNDM's latest filing, up from $2.7 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $6.6 million in Q2 2017 to a low of $2.6 million in Q2 2015.
  • Average Work In Process over 5 years is $4.2 million, with a median of $3.8 million recorded in 2017.
  • Peak YoY movement for Work In Process: skyrocketed 74.78% in 2016, then tumbled 52.51% in 2018.
  • A 5-year view of Work In Process shows it stood at $3.4 million in 2015, then grew by 29.49% to $4.4 million in 2016, then dropped by 13.27% to $3.8 million in 2017, then decreased by 28.91% to $2.7 million in 2018, then skyrocketed by 31.37% to $3.6 million in 2019.
  • Per Business Quant, the three most recent readings for TNDM's Work In Process are $3.6 million (Q1 2019), $2.7 million (Q4 2018), and $4.5 million (Q3 2018).